Form D · Biotechnology
MINERVA BIOTECHNOLOGIES Corp
Waltham, MA · CIK 0001087376
Offering snapshot reported Dec 5, 2023 · SEC filing
- Reported sold
- $4.52M Offering amount: $8M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2023 | Initial | $4,515,000 | No comparison | 9 | SEC filing |
| Jan 4, 2023 | Amendment | $327,720 | $202,470vs Feb 23, 2022 | 5 | SEC filing |
| Feb 23, 2022 | Initial | $125,250 | No comparison | 1 | SEC filing |
| Jan 28, 2022 | Amendment | $24,073,157 | $22,528,149vs Oct 30, 2019 | 65 | SEC filing |
| Oct 30, 2019 | Initial | $1,545,008 | No comparison | 7 | SEC filing |
| Apr 5, 2019 | Initial | $4,231,000 | No comparison | 9 | SEC filing |
| Oct 2, 2018 | Initial | $29,342,194 | No comparison | 79 | SEC filing |
| Oct 24, 2014 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Nov 17, 2010 | Initial | $4,634,580 | No comparison | 17 | SEC filing |
| Feb 23, 2010 | Initial | $1,605,632 | No comparison | 20 | SEC filing |
| Aug 18, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 5, 2006 | Paper | Not reported | No comparison | Not reported | |
| Apr 5, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498854
Source: Form D, filed Dec 5, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald R. Axelrod | Director |
| Cynthia Bamdad | Director, Executive |
| James Bridges | Director |
| Lawrence Coolidge | Director |
| Kenneth Kosik | Director |
| Joseph Anthony Nathan | Director |
| Kenneth Reed | Director |
| Normand F. Smith | Director |
| Robert Staszewski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
40 Bear Hill Road
Waltham, MA, 02451
Waltham, MA, 02451